KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Notes Payables (2020)

Ginkgo Bioworks Holdings (DNA) has disclosed Notes Payables for 1 consecutive years, with $300000.0 as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Notes Payables changed N/A year-over-year to $300000.0, compared with a TTM value of $300000.0 through Dec 2020, changed N/A, and an annual FY2020 reading of $300000.0, changed N/A over the prior year.
  • Notes Payables was $300000.0 for Q4 2020 at Ginkgo Bioworks Holdings.
  • Across five years, Notes Payables topped out at $300000.0 in Q4 2020 and bottomed at $300000.0 in Q4 2020.